Tech Company Financing Transactions

SpectraWAVE Funding Round

SpectraWAVE secured a $50 million Series B financing round on 9/11/2024. Investors included Johnson & Johnson Innovation, Deerfield Management Company and Lumira Ventures.

Transaction Overview

Company Name
Announced On
9/11/2024
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance commercial expansion and product additions to its 510k-cleared HyperVue� Imaging System.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
12 Oak Park Dr.
Bedford, MA 01730
USA
Email Address
Not Recorded
Overview
SpectraWAVE, located in Bedford, MA, is a privately held medical device company founded in 2017 to improve coronary artery disease (CAD) outcomes with photonics. CAD, the buildup of plaque in the wall of the arteries that supply blood to the heart, affects 18.2 million adults age 20 and older.
Profile
SpectraWAVE LinkedIn Company Profile
Social Media
SpectraWAVE Company Twitter Account
Company News
SpectraWAVE News
Facebook
SpectraWAVE on Facebook
YouTube
SpectraWAVE on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Eman Namati
  Eman Namati LinkedIn Profile  Eman Namati Twitter Account  Eman Namati News  Eman Namati on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/11/2024: SafetyCulture venture capital transaction
Next: 9/11/2024: Brico venture capital transaction

 

Share this article

 


News on VC Transactions

We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary